ACTide to Attend PhUSE EU Connect 2019
ACTide is to attend PhUSE EU Connect 2019, which will be taking place from 10 to 13 November in Amsterdam, The Netherlands.
ACTide is to attend PhUSE EU Connect 2019, which will be taking place from 10 to 13 November in Amsterdam, The Netherlands.
Join NSF’s Lynne Byers, Catherine Kay, Howard Broadbridge and Martin Krainz at the CPhI Worldwide exhibition on November 5-7, 2019.
Porton Biopharma Ltd (PBL) has today announced that it has signed a modification to its contract (HHSN272201600045C) with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases (NIAID) to advance a next-generation intra-nasal anthrax vaccine into the clinical-trial phase.
The grand opening of Novo Nordisk Pharmatech A/S new branch office in Singapore on October 15 was celebrated together with customers, employees and other stakeholders.
The transaction creates a single access point for medical device and pharma/biotech product developers seeking integrated, expert services throughout the entire product lifecycle.
Dry-powder inhalation (DPI) is a major drug delivery technology for the treatment of respiratory diseases and increasingly for systemic drug
TLX Cargo Thermal Blankets are now available worldwide in EMBALL’ISO commercial network. Pharmaceutical companies now have one customer consultant for the purchase or rental of passive isothermal packaging and thermal covers.
The WAB US Corp has announced it is going to participate at AAPS PharmSci 360.
Enamine REAL database of synthetic compounds accessible via UCSF’s online ZINC platform.
SCHOTT Pharmaceutical Systems has announced it will be exhibiting at CPhI Worldwide 2019.